On Target Podcast

News EN ↓ 11 episodes

On Target: Targeting What Matters in Testing is a podcast dedicated to exploring the evolving landscape of diagnostics and its critical role in the development of precision healthcare. Testing is at the center of healthcare like never before, thanks to advancements in genomic sequencing, AI-driven diagnostics, biomarker-driven therapies, and home testing. Healthcare systems are adapting to integrate these technologies effectively, and regulators are trying to keep pace with innovation. Co-hosted by industry experts, On Target features conversations with testing company and laboratory executi...

Author

On Target Podcast

Episodes

Broad life-sciences and diagnostics expertise at scale - On Target Podcast w/ Madhuri Hegde, SVP & CSO, Revvity 07.07.2026 32:44

Madhuri Hegde, SVP and CSO of Revvity, discusses how her company leverages partnerships and broad expertise in both life sciences and diagnostics to solve patient problems.

Broad conversation on AI, Cdx, rare diseases, and more - On Target Podcast w/ Janet Woodcock, Former deputy commissioner, FDA 24.06.2026 41:41

Janet Woodcock, distinguished FDA veteran and past deputy commissioner of the agency, gives us her take on AI, companion diagnostics, drugs for rare diseases, and how to earn trust for new technology.

Early cancer detection using extracellular vesicles - On Target Podcast w/ Dawn Mattoon, CEO, Mercy BioAnalytics 02.06.2026 33:01

Dawn Mattoon, CEO of Mercy Bioanalytics, explains how her company is using extracellular vesicles to successfully diagnose early stage cancer.

Using biomarkers to monitor multiple sclerosis - On Target Podcast w/ Doug Biehn, President and CEO, Octave Biosciences 19.05.2026 29:32

Doug Biehn, President and CEO of Octave Biosciences, talks about the difference that a biomarker test can make in the management of multiple sclerosis.

Identifying hard-to-diagnose infections in cancer patients - On Target Podcast w/ Alec Ford, CEO, Karius 12.05.2026 28:00

Alec Ford, CEO of Karius, shares how genomics and AI are expanding what's possible in infectious disease diagnostics — and why getting the right answer faster can make all the difference for immunocompromised patients battling cancer and other serious conditions.

Advancing multiple-myeloma and blood-cancer dx with WGS - On Target Podcast w/ Irene Ghobrial, Co-Founder, Predicta Biosciences 28.04.2026 27:05

Irene Ghobrial, founder of Predicta Biosciences, explains how bringing whole-genome sequencing into the clinic is taking diagnosis and treatment of multiple myeloma and blood cancers to a new level of precision.

"Expanding genomic analysis with optical genome mapping - On Target Podcast w/ Alka Chaubey CMO, Bionano Genomics" 14.04.2026 23:31

Alka Chaubey, CMO of Bionano Genomics, explains how optical genome mapping addresses the unmet needs of cytogenomics - and what it takes to get pathbreaking new technology into the clinic.

Using fragmentomics for early cancer detection - On Target Podcast w/ Susan Tousi CEO of Delfi 31.03.2026 44:30

Susan Tousi, CEO of DELFI Diagnostics, shares how her company is using AI and fragmentomics to make liquid biopsy more accessible and cancer less deadly.

Integrating genomics into standard patient care - On Target Podcast w/ James Lu Co-Founder and CEO of Helix 19.03.2026 24:07

James Lu, co-founder and CEO of Helix, tells us what his company is doing to make genomics part of the standard portfolio of health-care data.

Expanding consumer-directed health - On Target Podcast w/ Julia Cheek Founder and CEO of Everlywell 05.03.2026 28:09

Julia Cheek, founder and CEO of Everlywell, shares how her company is working to change not only the way people access, use, and understand home tests, but the way home tests fit into the entire landscape of medicine.

Rapid genomic sequencing for rare diseases - On Target Podcast w/ Katherine Stueland CEO of GeneDx 15.02.2026 33:39

Katherine Stueland, CEO of GeneDx, shares how her company is scaling whole-genome and exome sequencing for the diagnosis of rare diseases.